By Ryan Davis (January 1, 2020, 12:04 PM EST) -- Several patent law issues will likely get attention from Congress this year, including efforts to reduce drug prices by limiting pharmaceutical patents, overhaul the law on patent eligibility and fix a constitutional flaw in the Patent Trial and Appeal Board. Here's what to watch.
Lawmakers introduced a slew of bills in 2019 aimed at curbing drug prices, and many of them included components that would alter patent law, such as by restricting the number of patents that could cover any one drug. Attorneys expect those efforts to get renewed attention in the coming year, since actions to cut drug...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!